Page 1

Consolidated Investment Analysis For NVIDIA Corp  Company Description 

NVIDIA Corporation (NVIDIA) is a provider of visual computing technologies and the inventor of the graphics processing unit (GPU). The Company's products are designed to generate graphics on workstations, personal computers, game consoles and mobile devices. NVIDIA serves the entertainment and consumer market with its GeForce graphics products, the professional design and visualization market with its Quadro graphics products, the computing market with its Tesla computing solutions products, and the mobile computing market with its Tegra system-on-a-chip products. NVIDIA operates in four major productline operating segments: the GPU business, the professional solutions business (PSB), the media and communications processor (MCP), business, and the consumer products business (CPB). The Company's GPU business is comprised primarily of its GeForce products that support desktop and notebook personal computers. Its PSB is comprised of its NVIDIA Quadro professional workstation products. Share Statistics   Symbol    Current Price  52wk Range  Avg Vol (3m) 

NVDA   14.86    8.65‐ 18.96  18,768,900 

     

     

EPS   Market Cap  52wk Change  P/E (ttm) 

0.37 8.58B  ‐5.27%  40.39 

Financial Summary

On November 11, 2010, NVIDIA Corp reported 3rd quarter 2011 earnings of 0.15 per share. This result exceeded the 0.14 consensus of the 26 analysts covering the company and under-performed last year's 3rd quarter results by -21.05%. The next earnings announcement is expected on February 18, 2011. NVIDIA Corp reported annual 2010 earnings of 0.43 per share on February 17, 2010. The next earnings announcement from NVIDIA Corp is expected the week of February 18, 2011. NVDA.O had 3rd quarter 2011 revenues of 843.81m. This missed the 844.04m consensus estimate of the 26 analysts following the company. This was 4.02% above the prior year's 3rd quarter results. NVDA.O had revenues for the full year 2010 of 3.33bn. This was -2.87% below the prior year's results.


Analyst Consensus Buy

Outperform

Hold

Underperform

Sell

No Opinion

This is the consensus forecast amongst 30 polled investment analysts. Analyst Detail

Buy

Outperform

Hold

Underperform

Sell

No Opinion

Latest

9

4

14

2

1

1

4 weeks ago

10

2

15

2

1

1

2 months ago

9

2

16

2

1

1

3 months ago

8

2

17

2

1

1

Last year

6

2

13

2

1

1

The 24 analysts offering 12 month price targets for NVIDIA Corp (NVDA:NSQ) have a median target of 14.38, with a high estimate of 19.00 and a low estimate of 9.00. The median estimate represents a -4.86% decrease from the last price of 15.11. Technical Analysis Chart 

 


Consolidated Investment Analysis for Huntington  Bancshares Inc.  Company Description  Huntington Bancshares Incorporated is a bank holding company. Through its subsidiaries, the Company provides full-service commercial and consumer banking services, mortgage banking services, automobile financing, equipment leasing, investment management, trust services, brokerage services, insurance service programs, and other financial products and services. The Huntington National Bank (the Bank) is its only bank subsidiary. As of December 31, 2009, the Bank had 340 banking offices in Ohio, 115 banking offices in Michigan, 56 banking offices in Pennsylvania, 50 banking offices in Indiana, 28 banking offices in West Virginia, 13 banking offices in Kentucky, 9 private banking offices, one foreign office in the Cayman Islands, and one foreign office in Hong Kong. Its segments include Retail and Business Banking, Commercial Banking, Commercial Real Estate, Auto Finance and Dealer Services (AFDS), and the Private Financial Group (PFG). A sixth group includes the Treasury function.  Share Statistics  Symbol   

HBAN  

EPS

Current Price   

6.72

Market Cap 

52wk Range 

3.60‐ 7.40 

52wk Change  80.16% 

Avg Vol (3m) 

14,358,500

P/E (ttm) 

‐0.42 4.82B  N/A 

Financial Summary 

On October 21, 2010, Huntington Bancshares Incorporated reported 3rd quarter 2010 earnings of 0.10 per share. This result exceeded the 0.06 consensus of the 17 analysts covering the companyand under-performed last year's 3rd quarter results by 0.43. The next earnings announcement is expected on January 17, 2011. Huntington Bancshares Incorporated reported annual 2009 losses of -6.23 per share on January 22, 2010. The next earnings announcement from Huntington Bancshares Incorporated is expected the week of January 17, 2011. HBAN.O had 3rd quarter 2010 revenues of 677.11m. This bettered the 660.57m consensus of the 7 analysts covering the company. This was 1.17% above the prior year's 3rd quarter results. HBAN.O had revenues for the full year 2009 of 2.43bn. This was 8.54% above the prior year's results.


Analyst Consensus  Buy

Outperform

Hold

Underperform

Sell

No Opinion

This is the consensus forecast amongst 20 polled investment analysts Analyst Detail

Buy

Outperform

Hold

Underperform

Sell

No Opinion

Latest

7

2

7

3

1

0

4 weeks ago

7

2

7

3

1

0

2 months ago

5

2

7

3

1

0

3 months ago

5

2

7

2

1

0

Last year

2

0

8

4

0

0

The 18 analysts offering 12 month price targets for Huntington Bancshares Incorporated (HBAN:NSQ) have a median target of 7.00, with a high estimate of 9.00 and a low estimate of 5.00. The median estimate represents a 7.86% increase from the last price of 6.49. Technical Analysis Chart 


Consolidated Investment Analysis For Teva  Pharmaceutical Industries  Teva Pharmaceutical Industries (NASDAQ: TEVA)  Company Description 

Teva Pharmaceutical Industries Limited (Teva) is a global pharmaceutical company that develops, produces and markets generic drugs covering all treatment categories. The Company has a pharmaceutical business, whose principal products are Copaxone for multiple sclerosis and Azilect for Parkinson's disease, respiratory products and women's health products. Teva's active pharmaceutical ingredient (API) business provides vertical integration to Teva's own pharmaceutical production. The Company's global operations are conducted in North America, Europe, Latin America, Asia and Israel. Teva has operations in more than 60 countries, including 38 finished dosage pharmaceutical manufacturing sites in 17 countries, 15 generic research and development (R&D) centers operating mostly within certain manufacturing sites and 21 API manufacturing sites around the world. Share Statistics   Symbol    TEVA    Current Price  52.63    52wk Range  46.99‐ 64.95  Avg Vol (3m)  6,069,120 

     

     

EPS   Market Cap  52wk Change  P/E (ttm) 

3.25 47.31B  0.34%  16.20 

Financial Summary 

On November 02, 2010, Teva Pharmaceutical Industries Ltd reported 3rd quarter 2010 earnings of 1.30 per share. This result was in line with the expectation of the one analyst following the company and exceeded last year's 3rd quarter results by 46.07%. The next earnings announcement is expected on February 14, 2011. Teva Pharmaceutical Industries Ltd reported annual 2009 earnings of 3.37 per share on February 16, 2010. TEVA.TA had 3rd quarter 2010 revenues of 4.25bn. This missed the 4.30bn estimate of the one analyst following the company. The same period last year the company did not report revenues. TEVA.TA had revenues for the full year 2009 of 13.90bn. This was 25.39% above the prior year's results.


Analyst Consensus  Buy

Outperform

Hold

Underperform

Sell

No Opinion

This is the consensus forecast amongst 4 polled investment analysts. Analyst Detail

Buy

Outperform

Hold

Underperform

Sell

No Opinion

Latest

2

2

0

0

0

0

4 weeks ago

2

2

0

0

0

0

2 months ago

1

3

1

0

0

0

3 months ago

1

3

1

0

0

0

Last year

2

2

2

0

0

1

Technical Analysis Chart 

       


Report Disclaimer  DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS WEBSITE OR  IN ONE OF OUR NEWSLETTERS. We are not registered as a securities broker‐dealer or an  investment advisor either within the U.S. Securities and Exchange Commission (the “SEC”) or  with any state securities regulatory authority. We are neither licensed nor qualified to provide  investment advice.  The information contained on our website or in any of our newsletters should be viewed as  commercial advertisement and is not intended to be investment advice. Any information found  on our website, or in any of our newsletters is not provided to any particular individual with a  view toward their individual circumstances. The information contained on our website, and in  any newsletter we distribute, is not an offer to buy or sell securities. We distribute opinions,  comments, and information free of charge exclusively to individuals who wish to receive them.  Our newsletter and website have been prepared for informational purposes only and are not  intended to be used as a complete source of information on any particular company. An  individual should never invest in the securities of any of the companies profiled based solely on  information contained in our report. Individuals should assume that all information contained  on our website or in one of our newsletters about profiled companies is not trustworthy unless  verified by their own independent research.  Any individual who chooses to invest in any securities should do so with caution. Investing in  securities is speculative and carries a high degree of risk; you may lose some or all of the money  that is invested. Always research your own investments and consult with a registered  investment adviser or licensed stock broker before investing.  This report is a service of Seo Freisin, Inc., a financial public relations firm that has been  compensated by the companies profiled. All direct and third party compensation received has  been disclosed on both, this newsletter, and on our website in accordance with section 17(b) of  the Securities Act of 1933. This compensation constitutes a conflict of interest as to our ability to   remain objective in our communication regarding the profiled companies. Seo Freisin, Inc.,  and/or its affiliates will hold, buy, and sell securities in the companies profiled. When  compensated in shares, all readers should be aware that it is our policy to liquidate   all shares immediately. We reserve the right to buy or sell the shares of any the companies  mentioned in any materials we produce at any time. This compensation constitutes a conflict of  interest as to our ability to remain objective in our communication regarding the profiled  companies.   ChartPoppers.com is a Web site wholly‐owned by Seo Freisin, Inc. Seo Freisin, Inc., has not been  compensated for any of the Companies mentioned in this report, we also do not own any shares  in the companies discussed in this report. 


Information contained in our report will contain “forward looking statements” as defined under  section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934.  Subscribers are cautioned not to place undue reliance upon these forward looking statements.  These forward looking statements are subject to a number of known and unknown risks and  uncertainties outside of our control that could cause actual operations or results to differ  materially from those anticipated. Factors that could affect performance include, but are not  limited to, those factors that are discussed in each profiled company’s most recent reports or  registration statements filed with the SEC. You should consider these factors in evaluating the  forward looking statements included in the report and not place undue reliance upon such  statements.  We are committed to providing factual information on the companies that are profiled.  However, we do not provide any assurance as to the accuracy or completeness of the  information provided, including information regarding a profiled company’s plans or ability to  effect any planned or proposed actions. We have no first‐hand knowledge of any profiled  company’s operations and therefore cannot comment on their capabilities, intent, resources,  nor experience and we make no attempt to do so. Statistical information, dollar amounts, and  market size data was provided by the subject company and related sources which we believe to  be reliable.  To the fullest extent of the law, we will not be liable to any person or entity for the quality,  accuracy, completeness, reliability, or timeliness of the information provided in this report, or  for any direct, indirect, consequential, incidental, special or punitive damages that may arise out  of the use of information we provide to any person or entity (including, but not limited to, lost  profits, loss opportunities, trading losses, and damages that may result from any inaccuracy or  incompleteness of this information).  We encourage you to invest carefully and read investment information available at the websites  of the SEC at http://www.sec.gov and FINRA at http://www.finra.org         

NVDA, HBAN, TEVA  

Company Description Financial Summary Share Statistics

Read more
Read more
Similar to
Popular now
Just for you